Skip to main
ADNT
ADNT logo

Adient (ADNT) Stock Forecast & Price Target

Adient (ADNT) Analyst Ratings

Based on 8 analyst ratings
Hold
Strong Buy 13%
Buy 13%
Hold 50%
Sell 25%
Strong Sell 0%

Bulls say

Adient, a leading seating supplier with approximately one-third of the global market, generated consolidated revenue of $14.7 billion in fiscal 2024, with a slight decline projected to $14.4 billion in fiscal 2025 as foreign exchange effects help mitigate losses from divested business. The company anticipates gaining additional market share through onshored production and targeted programs, potentially doubling these gains. Moreover, management expects to achieve margin expansion to between 5.0% and 5.5% over the next two to three years, reflecting confidence in financial performance and operational efficiency.

Bears say

Adient faces significant challenges stemming from its post-spin legacy issues, including loss-making metals contracts and uncompetitive plants, which have hindered profitability and cash flow for several years. In addition, the European, Middle Eastern, and African (EMEA) regions are experiencing decreased vehicle production and an unfavorable production mix, further adversely affecting the company’s revenue outlook. Geopolitical and macroeconomic factors are expected to continue to pose headwinds to production in Europe, exacerbating the company’s financial difficulties.

Adient (ADNT) has been analyzed by 8 analysts, with a consensus rating of Hold. 13% of analysts recommend a Strong Buy, 13% recommend Buy, 50% suggest Holding, 25% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Adient and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Adient (ADNT) Forecast

Analysts have given Adient (ADNT) a Hold based on their latest research and market trends.

According to 8 analysts, Adient (ADNT) has a Hold consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $22.69, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $22.69, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Adient (ADNT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.